Asthma Trial, Recruiting NCT07402200 Sponsor: University Hospital, Montpellier Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07402200
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your child is already taking part in the SynAir-G observational study
  • Both the child and their parent(s) or guardian(s) are willing to follow the study procedures
  • The child's parent(s) or guardian(s) are able to give written consent for the child to take part
  • For the "case" group (children with allergic conditions): Your child has at least one of the following in the past 12 months: diagnosed asthma, allergic rhinitis (hay fever), eczema, or food allergy — or symptoms such as wheezing, a blocked/runny nose without a cold, a nighttime dry cough, or an itchy rash in typical eczema areas
  • For the "control" group (children without allergic conditions): Your child has none of the above diagnoses or symptoms

Who may not be able to join:

  • The child or their parent(s)/guardian(s) refuse to take part or to give consent
  • The child or their parent(s)/guardian(s) are not willing to follow the study procedures
  • The family does not read or write in French
  • The family is planning a long trip away from the region that would prevent them from attending the required study visits
  • The child is not registered with the French social security system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 February 2026
Est. completion
1 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Statistically significant differences in spirometric parameter, Peak Flow, between case and control groups; Statistically significant differences in FeNO measurements between case and control groups; Evaluation of statistically significant differences in spirometric parameter, FEV, between case and control groups; Evaluation of statistically significant differences in spirometric parameter, FVC, between case and control groups; Statistically significant differences in the spirometric parameter, FEV₁/FVC ratio, between case and control groups; Statistically significant differences in spirometri...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov